ICLRNasdaqServices-Commercial Physical & Biological Research
ICON PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 27, 2026
$168.14−2.04 (-1.20%)
Close on Oct 19, 2026
- Market cap
- $13.01B
- P/E (TTM)
- 300.2
- Dividend yield
- –
Share price
−$16.92 (−9.14%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
ICON PLC grew revenue 1.7% to $8.29B over the twelve months to Jun 30, 2026. Operating income fell 72.8% to $296.50M, moving the operating margin from 13.4% to 3.6%. Free cash flow was $883.82M, down 10.7% from a year earlier.
Revenue
$8.29B
+1.7% vs. a year earlier
Operating income
$296.50M
-72.8% vs. a year earlier
Free cash flow
$883.82M
-10.7% vs. a year earlier
EPS, diluted
$0.56
-94.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $13.01B
- P/E ratio
- 300.2
- Price to sales
- 1.57
- Price to book
- 1.39
- Dividend yield
- –
- Free cash flow yield
- 6.79%
Fundamentals
- Revenue
- $8.29B
- Net income
- $42.34M
- EPS, diluted
- $0.56
- Free cash flow
- $883.82M
- Book value per share
- $121.21
- Diluted shares
- 77M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$8.29B+1.7% YoY
Gross profit
$1.98B-17.0% YoY
Operating income
$296.50M-72.8% YoY
Net income
$42.34M-95.1% YoY
EPS, diluted
$0.56-94.8% YoY
Free cash flow
$883.82M-10.7% YoY
Reported periodTrailing twelve months